HK1109594A1 - Improved quenching methods for red blood cell inactivation process - Google Patents

Improved quenching methods for red blood cell inactivation process

Info

Publication number: HK1109594A1
Authority: HK; Hong Kong
Prior art keywords: red blood; blood cell; methods; improved; quencher
Prior art date: 2004-10-29

Application number

HK08103739.2A

Other languages

English (en)

Inventor

Adonis Stassinopoulos

Original Assignee

Cerus Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-29

Filing date

2008-04-02

Publication date

2008-06-13

2008-04-02 Application filed by Cerus Corp filed Critical Cerus Corp

2008-06-13 Publication of HK1109594A1 publication Critical patent/HK1109594A1/xx

Links

238000000034 method Methods 0.000 title abstract 5
210000003743 erythrocyte Anatomy 0.000 title abstract 3
238000010791 quenching Methods 0.000 title abstract 3
230000000171 quenching effect Effects 0.000 title abstract 3
230000002779 inactivation Effects 0.000 title 1
125000000524 functional group Chemical group 0.000 abstract 2
RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
108010024636 Glutathione Proteins 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
-1 glutathione Chemical class 0.000 abstract 1
229960003180 glutathione Drugs 0.000 abstract 1
230000000415 inactivating effect Effects 0.000 abstract 1
239000003446 ligand Substances 0.000 abstract 1
150000007523 nucleic acids Chemical class 0.000 abstract 1
102000039446 nucleic acids Human genes 0.000 abstract 1
108020004707 nucleic acids Proteins 0.000 abstract 1
230000000269 nucleophilic effect Effects 0.000 abstract 1
244000052769 pathogen Species 0.000 abstract 1
230000001717 pathogenic effect Effects 0.000 abstract 1
238000007086 side reaction Methods 0.000 abstract 1
150000003573 thiols Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
- A61L2/0088—Liquid substances
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0215—Disinfecting agents, e.g. antimicrobials for preserving living parts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Environmental Sciences (AREA)
Epidemiology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Dentistry (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Tropical Medicine & Parasitology (AREA)
Hematology (AREA)
Virology (AREA)
Diabetes (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Materials For Medical Uses (AREA)

HK08103739.2A 2004-10-29 2008-04-02 Improved quenching methods for red blood cell inactivation process HK1109594A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US62317704P	2004-10-29	2004-10-29
PCT/US2005/039392 WO2006050328A1 (en)	2004-10-29	2005-10-31	Improved quenching methods for red blood cell inactivation process

Publications (1)

Publication Number	Publication Date
HK1109594A1 true HK1109594A1 (en)	2008-06-13

Family

ID=35789172

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK08103739.2A HK1109594A1 (en)	2004-10-29	2008-04-02	Improved quenching methods for red blood cell inactivation process

Country Status (13)

Country	Link
US (1)	US7655392B2 (xx)
EP (1)	EP1838355B1 (xx)
JP (3)	JP5346468B2 (xx)
CN (2)	CN101094692A (xx)
AU (2)	AU2005302256B2 (xx)
BR (1)	BRPI0518198B8 (xx)
CA (1)	CA2585621C (xx)
DK (1)	DK1838355T3 (xx)
ES (1)	ES2429088T3 (xx)
HK (1)	HK1109594A1 (xx)
PL (1)	PL1838355T3 (xx)
PT (1)	PT1838355E (xx)
WO (1)	WO2006050328A1 (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69826521T2 (de) *	1998-01-06	2005-09-29	Cerus Corp., Concord	Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien
DK1838355T3 (da)	2004-10-29	2013-10-28	Cerus Corp	Forbedrede quenching-fremgangsmåder til erytrocyt-inaktiveringsfremgangsmåde
AU2009233807B2 (en) *	2008-04-09	2014-11-27	Cerus Corporation	Improved quenching methods for red blood cell pathogen inactivation
US11284616B2 (en)	2010-05-05	2022-03-29	Hemanext Inc.	Irradiation of red blood cells and anaerobic storage
US9199016B2 (en)	2009-10-12	2015-12-01	New Health Sciences, Inc.	System for extended storage of red blood cells and methods of use
US7989593B1 (en)	2010-05-27	2011-08-02	Bing Lou Wong	Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof
US8048856B1 (en)	2010-06-23	2011-11-01	Billion King, Ltd.	Treatment methods using a heat stable oxygen carrier-containing pharmaceutical composition
US7932356B1 (en)	2010-06-23	2011-04-26	Bing Lou Wong	Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition
US8084581B1 (en)	2011-04-29	2011-12-27	Bing Lou Wong	Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus
US20130052232A1 (en)	2011-08-31	2013-02-28	Bing Lou Wong	Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking
US20160081328A1 (en) *	2013-05-10	2016-03-24	President And Fellows Of Harvard College	Solutions for Red Blood Cells
EA201790265A1 (ru)	2014-07-23	2017-07-31	Сирус Корпорейшн	Способы получения тромбоцит-содержащих продуктов
IL299978B1 (en)	2015-03-10	2024-04-01	Hemanext Inc	Single-use oxygen reduction kits, devices and methods for their use
KR20240067253A (ko)	2015-04-23	2024-05-16	헤마넥스트 인코포레이티드	혐기성 혈액 저장 용기
MX2017014812A (es)	2015-05-18	2018-05-11	New Health Sciences Inc	Metodos para el almacenamiento de sangre completa y composiciones de esta.
CN108135936A (zh)	2015-06-26	2018-06-08	塞鲁斯公司	冷沉淀物组合物及其制备方法
CA3003097A1 (en)	2015-10-23	2017-04-27	Cerus Corporation	Plasma compositions and methods of use thereof
CN109195632A (zh) *	2016-05-27	2019-01-11	新健康科学股份有限公司	厌氧血液储存和病原体失活方法
WO2018119462A1 (en)	2016-12-23	2018-06-28	Cerus Corporation	Systems and methods for testing and screening using compound bound substrates
US20190321407A1 (en) *	2016-12-31	2019-10-24	Cerus Corporation	Compositions and methods for preparation of red blood cells
AU2018227586B2 (en)	2017-03-03	2023-12-21	Cerus Corporation	Kits and methods for preparing pathogen-inactivated platelet compositions
AU2018338097B2 (en)	2017-09-20	2023-07-13	Cerus Corporation	Compositions and methods for pathogen inactivation of platelets
EA202091602A1 (ru)	2017-12-29	2020-10-19	Сирус Корпорейшн	Системы и способы для обработки биологических жидкостей
CA3107314A1 (en) *	2018-07-27	2020-01-30	Zata Pharmaceuticals, Inc.	Method for pathogens, microorganisms, and parasites inactivation
EA202190810A1 (ru) *	2018-09-20	2021-08-23	Сирус Корпорейшн	Способы и наборы для получения цельной крови с инактивированным патогеном
MX2021015653A (es)	2019-06-22	2022-04-11	Cerus Corp	Sistemas de tratamiento de fluidos biologicos.
US11883544B2 (en)	2019-06-28	2024-01-30	Cerus Corporation	System and methods for implementing a biological fluid treatment device
EP4240757A2 (en)	2020-11-09	2023-09-13	Takeda Pharmaceutical Company Limited	Purification of fviii from plasma using silicon oxide adsorption

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2402665A (en)	1942-11-12	1946-06-25	Du Pont	Chemical process
IT1093275B (it)	1978-01-26	1985-07-19	Snam Progetti	Composizione adatta alla purificazione del sangue e suoi impieghi
US4337269A (en)	1979-07-23	1982-06-29	Sutton Laboratories, Inc.	Preservative compositions
US4748120A (en)	1983-05-02	1988-05-31	Diamond Scientific Co.	Photochemical decontamination treatment of whole blood or blood components
US4727027A (en)	1983-05-02	1988-02-23	Diamond Scientific Co.	Photochemical decontamination treatment of whole blood or blood components
US5281579A (en)	1984-03-23	1994-01-25	Baxter International Inc.	Purified virus-free hemoglobin solutions and method for making same
US4971760A (en)	1986-03-10	1990-11-20	University Of Southern California	Novel method for disinfecting red blood cells, blood platelets, blood plasma, and optical corneas and sclerae
US4944920A (en)	1986-08-01	1990-07-31	University Of Southern California	Novel method to treat blood
US4920143A (en)	1987-04-23	1990-04-24	University Of British Columbia	Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5094960A (en)	1988-10-07	1992-03-10	New York Blood Center, Inc.	Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
US5055485A (en)	1988-12-02	1991-10-08	New York Blood Center, Inc.	Inactivation of viruses in cell- and protein-containing compositions using aryl diol epoxides
US5587490A (en)	1990-04-16	1996-12-24	Credit Managers Association Of California	Method of inactivation of viral and bacterial blood contaminants
US5418130A (en)	1990-04-16	1995-05-23	Cryopharm Corporation	Method of inactivation of viral and bacterial blood contaminants
US5232844A (en)	1990-05-15	1993-08-03	New York Blood Center	Photodynamic inactivation of viruses in cell-containing compositions
US5120649A (en)	1990-05-15	1992-06-09	New York Blood Center, Inc.	Photodynamic inactivation of viruses in blood cell-containing compositions
US5658722A (en)	1990-05-15	1997-08-19	New York Blood Center, Inc.	Process for the sterilization of biological compositions using UVA1 irradiation
US5753258A (en)	1990-10-19	1998-05-19	University Of Florida	Artificial viral envelopes
GB9218581D0 (en)	1992-09-02	1992-10-14	Pall Corp	Removal of unwanted fluids from processed blood products
ZA944488B (en)	1993-06-23	1995-02-15	New York Blood Center Inc	System for viral inactivation of blood
US5591350A (en)	1994-04-15	1997-01-07	Pall Corporation	Iodine disinfection method using a gaseous iodine treated porous medium
SE9402472L (sv)	1994-07-13	1996-01-14	Forskarpatent I Linkoeping Ab	Modifierade ytor
US5522385A (en)	1994-09-27	1996-06-04	Aradigm Corporation	Dynamic particle size control for aerosolized drug delivery
US5660731A (en)	1994-11-08	1997-08-26	Pall Corporation	Filter for separating photoactive agent
US5691132A (en)	1994-11-14	1997-11-25	Cerus Corporation	Method for inactivating pathogens in red cell compositions using quinacrine mustard
US5637451A (en)	1995-03-29	1997-06-10	New York Blood Center, Inc.	Photodynamic treatment of red blood cells with phthalocyanines and red light at higher light fluence rates is protective of red blood cells
US6177441B1 (en)	1995-06-05	2001-01-23	Cerus Corporation	Treating red blood cell solutions with anti-viral agents
ES2337852T3 (es)	1995-06-07	2010-04-29	Cerus Corporation	Metodos y dispositivos para la eliminacion de psoralenos de productos sanguineos.
US20020192632A1 (en)	1995-06-07	2002-12-19	Hei Derek J.	Method and devices for the removal of psoralens from blood products
WO1996039816A1 (en)	1995-06-07	1996-12-19	Baxter International Inc.	Method of inactivation of viral and bacterial blood contaminants
US6544727B1 (en)	1995-06-07	2003-04-08	Cerus Corporation	Methods and devices for the removal of psoralens from blood products
EP0773716A4 (en)	1995-06-07	1999-08-04	Cerus Corp	TREATMENT OF RED BLOOD CELL SOLUTIONS WITH ANTIVRAL ACTIVE SUBSTANCES
WO1997002028A1 (en)	1995-06-29	1997-01-23	Hemasure, Inc.	Inactivation of pathogens using hydroxymethylamines
US6114108A (en)	1995-08-29	2000-09-05	V.I. Technologies, Inc.	Methods and compositions for the selective modification of viral nucleic acids
US6136586A (en)	1995-08-29	2000-10-24	Vi Technologies, Inc.	Methods for the selective modification of viral nucleic acids
WO1997016966A1 (en)	1995-11-06	1997-05-15	New York Blood Center, Inc.	Viral inactivation treatment of red blood cells using phthalocyanines and red light
AU1085697A (en)	1995-11-21	1997-06-11	Pall Corporation	Inactivation method and system in biological fluids
US6514987B1 (en)	1997-01-06	2003-02-04	Cerus Corporation	Frangible compounds for pathogen inactivation
US20010018179A1 (en)	1998-01-06	2001-08-30	Derek J. Hei	Batch devices for the reduction of compounds from biological compositions containing cells and methods of use
US20010009756A1 (en)	1998-01-06	2001-07-26	Derek Hei	Flow devices for the reduction of compounds from biological compositions and methods of use
AU744089C (en)	1997-01-06	2003-07-31	Cerus Corporation	Frangible compounds for pathogen inactivation
US6093725A (en)	1997-01-06	2000-07-25	Cerus Corporation	Frangible compounds for pathogen inactivation
US6093564A (en)	1997-10-03	2000-07-25	V.I. Technologies, Inc.	Methods and compositions for the selective modification of nucleic acids
DE69826521T2 (de)	1998-01-06	2005-09-29	Cerus Corp., Concord	Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien
US6277337B1 (en) *	1998-07-21	2001-08-21	Gambro, Inc.	Method and apparatus for inactivation of biological contaminants using photosensitizers
US6150109A (en)	1999-01-25	2000-11-21	V. I. TECHNOLOGIES, Inc.	Lipophilic quenching of viral inactivating agents
EP1284743A2 (en) *	2000-05-31	2003-02-26	Cerus Corporation	Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity
CN100417325C (zh) *	2000-11-04	2008-09-10	王祥文	卫生灭菌消毒剂
EP1365750A2 (en) *	2000-12-21	2003-12-03	Cerus Corporation	Methods for inactivation of pathogens in biological materials
CN1186099C (zh) *	2001-12-13	2005-01-26	孙岩军	麻醉机呼吸回路清洗消毒的方法及其操作步骤
DK1838355T3 (da)	2004-10-29	2013-10-28	Cerus Corp	Forbedrede quenching-fremgangsmåder til erytrocyt-inaktiveringsfremgangsmåde

2005
- 2005-10-31 DK DK05821102.0T patent/DK1838355T3/da active
- 2005-10-31 US US11/264,195 patent/US7655392B2/en active Active
- 2005-10-31 WO PCT/US2005/039392 patent/WO2006050328A1/en active Application Filing
- 2005-10-31 PL PL05821102T patent/PL1838355T3/pl unknown
- 2005-10-31 CN CNA2005800453138A patent/CN101094692A/zh active Pending
- 2005-10-31 PT PT58211020T patent/PT1838355E/pt unknown
- 2005-10-31 CA CA2585621A patent/CA2585621C/en active Active
- 2005-10-31 EP EP05821102.0A patent/EP1838355B1/en active Active
- 2005-10-31 CN CN201410112134.2A patent/CN103961731B/zh active Active
- 2005-10-31 BR BRPI0518198A patent/BRPI0518198B8/pt not_active IP Right Cessation
- 2005-10-31 JP JP2007539281A patent/JP5346468B2/ja active Active
- 2005-10-31 AU AU2005302256A patent/AU2005302256B2/en not_active Ceased
- 2005-10-31 ES ES05821102T patent/ES2429088T3/es active Active
2008
- 2008-04-02 HK HK08103739.2A patent/HK1109594A1/xx unknown
2011
- 2011-04-06 AU AU2011201554A patent/AU2011201554B2/en not_active Ceased
2012
- 2012-03-07 JP JP2012050837A patent/JP5718840B2/ja active Active
2013
- 2013-09-27 JP JP2013200906A patent/JP2013256537A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
JP5346468B2 (ja)	2013-11-20
ES2429088T3 (es)	2013-11-13
BRPI0518198B8 (pt)	2021-06-22
AU2011201554B2 (en)	2012-04-26
CA2585621C (en)	2015-12-15
PT1838355E (pt)	2013-11-07
EP1838355A1 (en)	2007-10-03
JP2012107068A (ja)	2012-06-07
JP2008518952A (ja)	2008-06-05
BRPI0518198B1 (pt)	2018-11-21
CA2585621A1 (en)	2006-05-11
DK1838355T3 (da)	2013-10-28
PL1838355T3 (pl)	2014-01-31
WO2006050328A1 (en)	2006-05-11
JP5718840B2 (ja)	2015-05-13
AU2005302256B2 (en)	2011-01-20
US20060115466A1 (en)	2006-06-01
CN103961731A (zh)	2014-08-06
AU2011201554A1 (en)	2011-04-28
CN103961731B (zh)	2017-01-18
CN101094692A (zh)	2007-12-26
EP1838355B1 (en)	2013-08-14
AU2005302256A1 (en)	2006-05-11
JP2013256537A (ja)	2013-12-26
US7655392B2 (en)	2010-02-02
BRPI0518198A (pt)	2008-11-04

Publication	Publication Date	Title
HK1109594A1 (en)	2008-06-13	Improved quenching methods for red blood cell inactivation process
ATE276771T1 (de)	2004-10-15	Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien
WO2005078097A3 (en)	2005-10-27	RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING MULTIFUNCTIONAL SHORT INTERFERING NUCLEIC ACID (Multifunctional siNA)
WO2005040180A3 (en)	2005-10-20	Antisense modulation of superoxide dismutase 1, soluble (sod-1) expression
MX2010010151A (es)	2010-10-25	Moduladores de cinasa aurora y metodo de uso.
TNSN06059A1 (en)	2007-10-03	Use of polypeptides of the cupredoxin family in cancer therapy
WO2003000707A8 (en)	2004-04-01	Antisense modulation of superoxide dismutase 1, soluble expression
HRP20030688B1 (hr)	2013-12-06	Arilni i heteroarilni urea chk1 inhibitori za uporabu kao poticajne tvari radiosensitizatori i kemosensitizatori
WO2002020500A3 (en)	2003-07-31	Materials and methods to potentiate cancer treatment
GB0417487D0 (en)	2004-09-08	Organic compound
HK1197656A1 (zh)	2015-02-06	糖原累積病型的療法
WO2004106495A3 (en)	2006-01-12	Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
ATE415962T1 (de)	2008-12-15	Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
WO2004087965A3 (en)	2004-11-25	Statistical analysis of regulatory factor binding sites of differentially expressed genes
HK1078593A1 (en)	2006-03-17	Antibody against a tumor-specific antigen as target
WO2004009024A3 (en)	2004-08-12	Modulation of protein kinase c-iota expression
DE602005026811D1 (de)	2011-04-21	Verfahren zur inhibierung von tumorzellwachstum mit foxm1 sirns
WO2003030725A3 (en)	2003-10-09	Pancreatic cancer diagnosis and therapies
WO2004009112A8 (en)	2005-09-15	Use of urease for inhibiting cancer cell growth
WO2003076610A3 (fr)	2004-04-08	Variants de kallikrein-2 et kallikrein-3 humaines et leurs utilisations
WO2004085614A3 (en)	2006-09-08	Nucleic acid molecules that are differentially regulated in a bipolar disorder and uses thereof
UA93538C2 (xx)	2011-02-25	Модулятори aurora-кіназ та їх застосування[модуляторы aurora-киназ и их применение
HK1074840A1 (en)	2005-11-25	Novel dithiolopyrrolones with therapeutic activity
WO2006014706A3 (en)	2006-06-01	Methotrexate derivatives useful for treating cancer and arthritis
WO2005006958A8 (en)	2005-06-23	Modulation of ceacam1 expression